NUVAXOVID

by Felicia Eddings, Pharm.D. | May 17, 2025 | News From Around The Web | 0 comments

STN: 125817
Proper Name: COVID-19 Vaccine, Adjuvanted
Tradename: NUVAXOVID
Manufacturer: Novavax, Inc.
Indication:

NUVAXOVID is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in adults 65 years and older.
NUVAXOVID is indicated for individuals 12 through 64 years who have at least one underlying condition that puts them at high risk for severe outcomes from COVID-19.

Product Information

Supporting Documents

Content current as of:

05/17/2025

Source

Save More With Pill Pals®

Pill Pass® Drug List starts at only $6.99, and shipping is FREE. No Insurance Needed.

Learn More

Shop with Confidence at Pill Pals® - We're The EXPRESS Pharmacy

Secure checkout, SSL protection, and trusted shopping safeguards for Pill Pals® customers.

Submit a Comment Cancel reply

Medically Reviewed By: Felicia Eddings, Pharm.D.

Clinical :: Oncology :: Nuclear :: Geriatric :: Regulatory :: Technology :: Consulting

"My passion is helping businesses, small and large, perform at their best." - Felicia Udoji-Eddings, Pharm.D.

Dr. Felicia Udoji-Eddings is the Founder and CEO of The Health Pals Company, a vertically integrated Healthcare System. As an experienced Clinical Pharmacy Leader, Pharmacy Consultant, Healthcare Executive, and Licensed Pharmacy Practitioner with deep backgrounds in Information Technology (IT), Scientific Research, and Business Management. Dr. Udoji-Eddings has a strong track record of exceptional performance in different business environments. A skilled Business Strategist, Dr. Udoji-Eddings has tackled complex problems and helped several organizations refocus their strategy in tough economic times. As a highly motivated and proactive individual, Felicia enjoys working with teams, in various capacities, to facilitate positive outcomes.

View all posts by this author